
Global Cardiac Rhythm Management Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
-
9584
-
Jan 2022
-
158
-
PDF
-
-
Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
“Global Cardiac Rhythm Management Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global cardiac rhythm management devices market report has been segmented on the basis of product type, end user, and region.
Global Cardiac Rhythm Management Devices Market: Overview
Cardiac rhythm management is a treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmias causes – palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices include pacemakers, cardiac resynchronization therapy devices, and implantable cardiac defibrillators.
Global Cardiac Rhythm Management Devices Market: Dynamics
Increasing prevalence of cardiovascular diseases such as cardiac arrhythmia, hypertension, and ischemic heart disease is a key factor expected to drive growth of the global market over the forecast period. According to WHO report, in 2016, cardiovascular diseases was the leading cause of deaths and estimated for 17.9 Mn deaths, globally.
In addition, technological advancements and innovative product launches in cardiac rhythm management devices are some other factors expected to further fuel growth of the target market over the forecast period. For instance, cardiac pacemakers coupled with advanced technologies offers factors such as improved battery life and MRI safe-pacemakers, delay progression of persistent atrial fibrillation (AF) in patients suffering from bradycardia.
Furthermore, development of remote technology includes remote follow-up – patient data periodically downloaded from the device, which enables clinicians to perform patients’ routine check-ups remotely is another factor expected to boost growth of the target market over the forecast period.
However, pacemaker surgery or installation of pacemakers in cardiac patients may result in various types of complications such as chance of infections, bleeding, swelling at the implantation area or nerve damage, etc. is a key factor expected to restrain growth of the global market over the forecast period. In addition, high cost and maintenance are some other factors expected to hamper growth of the target market over the forecast period.
Innovative product development of new MRI-labeled devices and increasing research and development activities for cardiac monitoring & cardiac rhythm management industry are expected to create lucrative opportunities for players operating in the target market over the forecast period. during the forecast period.
Global Cardiac Rhythm Management Devices Market: Segment Analysis
Among product type, the defibrillators segment is expected to hold major share in terms of revenue over the forecast period, owing to increasing technological advancements in implantable devices and rising awareness regarding the need of Automated External Defibrillators (AEDs).
Among end user, the hospitals segment is expected to account for highest growth rate over the forecast period, owing to increasing rate of patient visits for diagnosis of CVD & CHD, increasing number of cardiac implant procedures.
Global Cardiac Rhythm Management Devices Market: Regional Analysis
The market in North America is expected to dominate in the market and is expected to maintain its dominance over the forecast period, owing to increasing incidence rate of cardiovascular diseases across various countries in the region. The market in Asia Pacific is expected to register significant growth over the forecast period, owing increasing demand for technologically advanced products for the target market and improving healthcare infrastructure among developing countries in the region.
Global Cardiac Rhythm Management Devices Market Segmentation:
Segmentation by product type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
Segmentation by end user:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Cardiac Resynchronization Therapy Devices
-
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- ABIOMED, Inc.
- BIOTRONIK SE & Co. KG
- Koninklijke Philips N.V.
- LivaNova PLC
- Cardiac Science Corporation
- Schiller AG
- ZOLL Medical Corporation
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!